Most people say they want to know their risk for Alzheimer’s dementia, fewer follow through
A new study from WashU Medicine examines the choices healthy research volunteers make when given the opportunity to learn their risk of developing Alzheimer’s disease dementia.
Understanding genetic factors behind a pediatric brain tumor
Researchers at WashU Medicine conducted a study to understand the genetic factors behind a pediatric brain tumor. Their findings could lead to new targeted therapies.
Temperature-controlled switch activates sperm, is key to fertility
WashU Medicine researchers led by Polina Lishko have identified a temperature-controlled switch in mouse sperm that changes their movements. The findings may offer new approaches for contraception and infertility treatment.
Brain decoder controls spinal cord stimulation
Biomedical engineering researchers at Washington University have developed a brain wave decoder that can help people with spinal cord injuries.
A neuro-quantum leap in finding optimal solutions
A computer scientist at Washington University has developed a problem-solving architecture modeled on neurobiology that leverages quantum mechanical behavior to guarantee optimal solutions to complex problems.
Two named to American Academy of Arts & Sciences
Two WashU faculty are among nearly 250 newly elected members of the American Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies. They are physicist Carl Bender, in Arts & Sciences, and immunologist Marco Colonna, at the School of Medicine.
Study examines overlap in causes of cancer, neurodevelopmental disorders
A new analysis, led by WashU Medicine researchers and published in Cell Genomics, examines how certain proteins in human cells are implicated in both cancer and neurodevelopmental disorders, but behave differently, complicating potential interventions.
Immunotherapy improves survival of patients with locally advanced head and neck cancer
An international clinical trial co-led by WashU Medicine found that the immunotherapy drug pembrolizumab added to standard-of-care therapy improved survival for patients with locally advanced head and neck cancer. Pembrolizumab helps the patient’s own immune cells attack and kill tumor cells.
Lenze receives William H. Danforth St. Louis Confluence Award
Shannon Lenze, at WashU Medicine, received the William H. Danforth St. Louis Confluence Award. Lenze was recognized for her partnership with the EleVATE Collaborative to improve maternal and infant health outcomes.
Class Acts: Mayah Clayton
Mayah Clayton doesn’t just study public health — she lives it. Through art, action and advocacy, she’s reframing how we see communities and create change.
Older Stories